Host: |
Rabbit |
Applications: |
WB/ELISA |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH 7.3. |
Purification: |
Affinity purification |
Concentration: |
Lot specific |
Dilution Range: |
WB:1:500-1:2000ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements. |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
PLCXD2 |
Uniprot ID: |
PLCX2_HUMAN |
Immunogen Region: |
1-305 |
Specificity: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-305 of human PLCXD2 (NP_001172035.1). |
Immunogen Sequence: |
MLAVRKARRKLRMGTICSPN PSGTKTSSEVCNADWMASLP PHLHNLPLSNLAIPGSHDSF SYWVDEKSPVGPDQTQAIKR LARISLVKKLMKKWSVTQNL TFREQLEAGIRYFDLRVSSK PGDADQEIYFIHGLFGIKVW DGLMEIDSFLTQHPQEIIFL DFNHFYAMDETHHKCLVLRI QEAFGNKLCPACSVESLTLR TLWEKNCQVLIFYHCPFYKQ YPFLWPGKKIPAPWANTTS |
Tissue Specificity | Widely expressed. |
Function | Catalyzes the hydrolysis of inositol from phosphatidylinositol (1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol), PI). Could also hydrolyze various multi-phosphorylated derivatives of PI, such as phosphatidylinositol-4,5 bisphosphate (PIP2), releasing inositol-1,4,5-trisphosphate (IP3) and the protein kinase C activator diacylglycerol (DAG), therefore mediating cell signaling (Probable). |
Protein Name | Pi-Plc X Domain-Containing Protein 2Phospholipase C X-Domain Containing Protein 2Plcxd-2 |
Cellular Localisation | Nucleus |
Alternative Antibody Names | Anti-Pi-Plc X Domain-Containing Protein 2 antibodyAnti-Phospholipase C X-Domain Containing Protein 2 antibodyAnti-Plcxd-2 antibodyAnti-PLCXD2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance